Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 2017

View Archived Issues

Novel Drosophila FXS model as promising screening strategy for therapeutic discovery

EpimAb Biotherapeutics and WuXi Biologics collaborate to advance development of EMB-01

Advaxis and BMS to test ADXS-DUAL plus Opdivo in metastatic cervical cancer

Sylentis initiates phase III HELIX study of SYL-1001as treatment of dry eye syndrome

Researchers design a novel antibody-powered DNA-based nanomachine

ProQR Therapeutics receives FDA fast track designation for QR-110

EMA's COMP recommends orphan medicinal product designation for Catalyst Biosciences' CB-2679d

Alnylam's givosiran receives FDA breakthrough therapy designation

IMIDomics enters strategic collaboration with Celgene

Eisai and Johns Hopkins announce extension of their drug discovery collaboration

Phase III HALO study of fremanezumab in migraine meets endpoints

FDA grants rare pediatric disease designation to Amicus' SD-101 for epidermolysis bullosa

New model reveals role of IRAK-M in rhinovirus infection

AstraZeneca presents serine-protein kinase ATM inhibitors

FDA grants priority review to Vyxeos NDA for AML

FDA approves Novo Nordisk's Rebinyn for hemophilia B

Roche divulges equilibrative nucleoside transporter 1 inhibitors

MabVax enters research agreement with Memorial Sloan Kettering for CAR T-cell therapeutics

Simon Fraser University and collaborator discover MRSA pyruvate kinase inhibitors

FDA approves first topical ocular formulation of cetirizine

R-Pharm CJSC presents MEK1/2 inhibitors

Phase III study of elafibranor in NASH recommended to continue by DSMB

Servier and ILTOO Pharma enter license agreement for ILT-101

Janssen Pharmaceutica discloses PDE2 inhibitors

FDA, EMA accept Pfizer's applications seeking to expand approved use of Sutent

Review committee recommends dose escalation in MEI Pharma's phase I study of ME-401

Minerva Neurosciences to amend MIN-202 agreement with Janssen

First patient enters Oncology Venture's phase I/II study of APO-010

Transient improvement seen in children with autism treated with suramin

FAM46A mutations found to cause a form of osteogenesis imperfecta

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...